ESG in Venture Capital: A Knowledge Round-up for Israeli VCs and Startups
We are proud to share New Era Capital Partners’ first white paper, ESG in Venture Capital. The paper tackles an emerging field of practice within venture capital that has torpedoed to the top of the global agenda, namely, the inclusion of environmental, social, and governance (ESG) considerations within investment process and their integration within the commercial activities of portfolio companies.
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive health, and precision oncology markets, announced they have secured $41.5M series C-2 funding round, led by New Era Capital Partners.